Prosecution Insights
Last updated: August 18, 2026

Examiner: PECKHAM, RICHARD GRANT

Tech Center 1600 • Art Units: 1600 1619 1626 1627 1653

This examiner grants 67% of resolved cases

Performance Statistics

67.2%
Allow Rate
+7.2% vs TC avg
182
Total Applications
+37.0%
Interview Lift
1195
Avg Prosecution Days
Based on 131 resolved cases, 2023–2026

Rejection Statute Breakdown

3.2%
§101 Eligibility
16.4%
§102 Novelty
29.1%
§103 Obviousness
29.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18557775 METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF XANTHINE OXIDASE INHIBITOR Non-Final OA LG CHEM, LTD.
17265139 HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF Non-Final OA DANA-FARBER CANCER INSTITUTE, INC.
18290328 NEW SUBSTITUTED PYRIDINES AS FUNGICIDES Non-Final OA BASF SE
17920797 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS II Non-Final OA BASF SE
17920795 USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS III Non-Final OA BASF SE
19347608 TREATMENT METHODS Final Rejection Levon Michael Khachigian
17906288 TREATMENT METHODS Final Rejection Levon Michael KHACHIGIAN
19242641 ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS Final Rejection Tarsus Pharmaceuticals, Inc.
18015775 SMALL MOLECULE INHIBITORS OF TDP-43 ACTIVITY AND USES THEREOF Non-Final OA Arizona Board of Regents on Behalf of the University of Arizona
18573372 CHROMANE IMAGING LIGANDS Non-Final OA The General Hospital Corporation
18835167 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Non-Final OA Mrja Therapeutics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month